X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-11-14 | NAGE | Niagen Bioscience, Inc. | Pamir Ozan | CFO | P - Purchase | $6.82 | +6,685 | 9,593 | +230% | +$45,616 | ||||||
2025-11-10 | USNA | Usana Health Sciences Inc | Winssinger Frederic J | Dir | S - Sale | $19.21 | -2,000 | 5,986 | -25% | -$38,420 | ||||||
2025-11-03 | USNA | Usana Health Sciences Inc | Fuller Gilbert A | Dir | S - Sale | $21.48 | -1,057 | 0 | -100% | -$22,704 | ||||||
2025-10-31 | USNA | Usana Health Sciences Inc | Fleming John Turman | Dir | S - Sale | $19.79 | -1,750 | 4,565 | -28% | -$34,633 | ||||||
2025-09-29 | CGC | Canopy Growth Corp | Lazzarato David Angelo | Dir | S - Sale | $1.58 | -15,677 | 103,387 | -13% | -$24,770 | ||||||
2025-09-29 | CGC | Canopy Growth Corp | Atkins M Shan | Dir | S - Sale | $1.58 | -2,216 | 43,464 | -5% | -$3,501 | ||||||
2025-09-29 | CGC | Canopy Growth Corp | Yanofsky Theresa | Dir | S - Sale | $1.58 | -10,408 | 73,952 | -12% | -$16,445 | ||||||
2025-09-29 | CGC | Canopy Growth Corp | Kruh Willy | Dir | S - Sale | $1.58 | -10,451 | 62,939 | -14% | -$16,513 | ||||||
2025-09-25 | MNMD | Mind Medicine (Mindmed) Inc. | Sullivan Mark | GC | S - Sale | $9.77 | -11,278 | 293,852 | -4% | -$110,186 | ||||||
2025-09-25 | MNMD | Mind Medicine (Mindmed) Inc. | Barrow Robert | CEO | S - Sale | $9.77 | -25,797 | 804,268 | -3% | -$252,037 | ||||||
2025-09-25 | MNMD | Mind Medicine (Mindmed) Inc. | Karlin Daniel | Chief Medical Officer | S - Sale | $9.77 | -7,704 | 430,625 | -2% | -$75,268 | ||||||
2025-09-22 | CGC | Canopy Growth Corp | Mongeau Luc | CEO | P - Purchase | $1.82 | +27,469 | 812,368 | +3% | +$49,994 | ||||||
| M | 2025-09-03 | CHUC | Charlie'S Holdings, Inc. | Carmines Edward | Dir | P - Purchase | $0.29 | +44,723 | 1,906,481 | +2% | +$13,140 | |||||
2025-08-22 | CGC | Canopy Growth Corp | Stewart Thomas Carlton | See Remarks | S - Sale | $1.74 | -5,768 | 68,203 | -8% | -$10,036 | ||||||
2025-08-22 | CGC | Canopy Growth Corp | Gedeon Christelle | See Remarks | S - Sale | $1.74 | -16,929 | 368,488 | -4% | -$29,456 | ||||||
| E | 2025-07-19 | HYEX | Healthy Extracts Inc. | Swanson Donald William | Pres, 10% | P - Purchase | $1.80 | +13,075,920 | 13,075,920 | New | +$23,536,656 | |||||
2025-08-18 | CGC | Canopy Growth Corp | Gedeon Christelle | See Remarks | S - Sale | $1.86 | -4,528 | 385,417 | -1% | -$8,422 | ||||||
2024-11-20 | TRUL | Trulieve Cannabis Corp. | Thronson Susan | Dir | P - Purchase | $6.30 | +3,968 | 50,845 | +8% | +$24,998 | ||||||
2024-11-21 | TRUL | Trulieve Cannabis Corp. | May Richard S. | Dir | P - Purchase | $6.05 | +1,610 | 570,096 | 0% | +$9,741 | ||||||
2025-08-07 | USNA | Usana Health Sciences Inc | Fuller Gilbert A | Dir | S - Sale | $29.10 | -1,058 | 0 | -100% | -$30,789 | ||||||
| D | 2025-07-31 | TLRY | Tilray Brands, Inc. | Gendel Mitchell | Global GC | P - Purchase | $0.58 | +6,000 | 698,287 | +1% | +$3,496 | |||||
2025-07-30 | USNA | Usana Health Sciences Inc | Mulham David Mulham | Chief Sales Officer | S - Sale | $30.26 | -3,515 | 9,260 | -28% | -$106,364 | ||||||
| M | 2025-06-11 | SNYR | Synergy Chc Corp. | Ross Jack | CEO, COB, 10% | P - Purchase | $2.85 | +27,900 | 4,795,757 | +1% | +$79,578 | |||||
2025-07-30 | TLRY | Tilray Brands, Inc. | Simon Irwin D | Pres, CEO | P - Purchase | $0.61 | +165,000 | 3,941,633 | +4% | +$100,106 | ||||||
2025-07-30 | TLRY | Tilray Brands, Inc. | Merton Carl A | CFO | P - Purchase | $0.60 | +33,500 | 798,069 | +4% | +$19,939 | ||||||
2025-06-30 | CGC | Canopy Growth Corp | Yanofsky Theresa | Dir | S - Sale | $1.23 | -10,425 | 84,360 | -11% | -$12,823 | ||||||
2025-06-30 | CGC | Canopy Growth Corp | Kruh Willy | Dir | S - Sale | $1.23 | -10,468 | 73,390 | -12% | -$12,876 | ||||||
2025-06-30 | CGC | Canopy Growth Corp | Lazzarato David Angelo | Dir | S - Sale | $1.23 | -15,701 | 119,064 | -12% | -$19,312 | ||||||
2025-06-25 | MNMD | Mind Medicine (Mindmed) Inc. | Sullivan Mark | GC | S - Sale | $6.80 | -11,491 | 305,130 | -4% | -$78,139 | ||||||
2025-06-25 | MNMD | Mind Medicine (Mindmed) Inc. | Karlin Daniel | Chief Medical Officer | S - Sale | $6.80 | -7,848 | 438,329 | -2% | -$53,366 | ||||||
2025-06-25 | MNMD | Mind Medicine (Mindmed) Inc. | Barrow Robert | CEO | S - Sale | $6.80 | -26,491 | 830,065 | -3% | -$180,139 | ||||||
2025-06-16 | CGC | Canopy Growth Corp | Hong Judy Eun Joo | CFO | S - Sale | $1.63 | -38,678 | 579,889 | -6% | -$62,866 | ||||||
2025-06-16 | CGC | Canopy Growth Corp | Gedeon Christelle | See Remarks | S - Sale | $1.47 | -9,555 | 389,945 | -2% | -$14,046 | ||||||
| M | 2025-06-02 | SNYR | Synergy Chc Corp. | Ross Jack | CEO, COB, 10% | P - Purchase | $1.85 | +16,100 | 4,767,857 | 0% | +$29,837 | |||||
2025-06-09 | USNA | Usana Health Sciences Inc | Fleming John Turman | Dir | S - Sale | $29.66 | -500 | 4,200 | -11% | -$14,829 | ||||||
2025-05-27 | USNA | Usana Health Sciences Inc | Noot Walter | COO | S - Sale | $30.29 | -6,291 | 0 | -100% | -$190,568 | ||||||
| M | 2025-04-11 | SNYR | Synergy Chc Corp. | Ross Jack | CEO, COB, 10% | P - Purchase | $2.05 | +5,300 | 4,751,757 | 0% | +$10,870 | |||||
| M | 2025-02-21 | SNYR | Synergy Chc Corp. | Ross Jack | CEO, COB, 10% | P - Purchase | $2.74 | +14,340 | 361,207 | +4% | +$39,350 | |||||
2025-05-09 | USNA | Usana Health Sciences Inc | Iiekking G Doug | CFO | S - Sale | $29.61 | -4,548 | 0 | -100% | -$134,662 | ||||||
| M | 2025-05-06 | BTMD | Biote Corp. | Guines LLC | 10% | P - Purchase | $3.26 | +447,714 | 4,622,748 | +11% | +$1,461,373 | |||||
| D | 2025-05-05 | USNA | Usana Health Sciences Inc | Fuller Gilbert A | Dir | S - Sale+OE | $29.82 | -674 | 0 | -100% | -$20,101 | |||||
2025-04-30 | BTMD | Biote Corp. | Guines LLC | 10% | P - Purchase | $3.30 | +1,933 | 4,175,034 | 0% | +$6,371 | ||||||
| D | 2025-04-17 | UPXI | Upexi, Inc. | Marshall Allan | CEO, 10% | P - Purchase | $2.28 | +657,895 | 884,318 | +291% | +$1,500,001 | |||||
2025-04-17 | UPXI | Upexi, Inc. | Norstrud Andrew James | CFO | P - Purchase | $2.28 | +43,860 | 159,138 | +38% | +$100,001 | ||||||
| D | 2025-04-17 | UPXI | Upexi, Inc. | Salkind Gene | Dir, 10% | P - Purchase | $2.28 | +241,229 | 365,127 | +195% | +$550,002 | |||||
2025-04-21 | BTMD | Biote Corp. | Guines LLC | 10% | P - Purchase | $3.27 | +8,801 | 4,173,101 | 0% | +$28,782 | ||||||
2025-04-22 | TLCC | Twinlab Consolidated Holdings, Inc. | Golisano B Thomas | 10% | S - Sale | $0.00 | -90,255,084 | 0 | -100% | -$0 | ||||||
| M | 2025-04-16 | BTMD | Biote Corp. | Guines LLC | 10% | P - Purchase | $3.29 | +7,874 | 4,164,300 | 0% | +$25,906 | |||||
2025-04-15 | FTLF | Fitlife Brands, Inc. | Ordal Todd | Dir | P - Purchase | $12.07 | +300 | 62,488 | 0% | +$3,621 | ||||||
2025-04-14 | FTLF | Fitlife Brands, Inc. | Lingenbrink Matthew | Dir | P - Purchase | $12.17 | +3,000 | 5,800 | +107% | +$36,510 | ||||||
| M | 2025-04-08 | BTMD | Biote Corp. | Guines LLC | 10% | P - Purchase | $3.21 | +48,439 | 4,156,426 | +1% | +$155,388 | |||||
| M | 2025-04-03 | BTMD | Biote Corp. | Guines LLC | 10% | P - Purchase | $3.19 | +74,440 | 4,107,987 | +2% | +$237,406 | |||||
| AM | 2025-03-13 | BTMD | Biote Corp. | Guines LLC | 10% | P - Purchase | $3.25 | +856,609 | 3,927,547 | +28% | +$2,784,419 | |||||
2025-03-31 | BTMD | Biote Corp. | Guines LLC | 10% | P - Purchase | $3.32 | +106,000 | 4,033,547 | +3% | +$351,920 | ||||||
2025-03-31 | CGC | Canopy Growth Corp | Yanofsky Theresa | Dir | S - Sale | $0.92 | -2,004 | 20,199 | -9% | -$1,844 | ||||||
2025-03-31 | CGC | Canopy Growth Corp | Lazzarato David Angelo | Dir | S - Sale | $0.92 | -3,004 | 22,886 | -12% | -$2,764 | ||||||
2025-03-31 | CGC | Canopy Growth Corp | Kruh Willy | Dir | S - Sale | $0.92 | -2,012 | 9,272 | -18% | -$1,851 | ||||||
2025-03-31 | FTLF | Fitlife Brands, Inc. | Lingenbrink Matthew | Dir | P - Purchase | $12.17 | +2,800 | 2,800 | New | +$34,089 | ||||||
2025-03-25 | MNMD | Mind Medicine (Mindmed) Inc. | Barrow Robert | CEO | S - Sale | $6.74 | -21,208 | 856,556 | -2% | -$142,942 | ||||||
2025-03-25 | MNMD | Mind Medicine (Mindmed) Inc. | Karlin Daniel | Chief Medical Officer | S - Sale | $6.74 | -6,836 | 446,177 | -2% | -$46,075 | ||||||
2025-03-25 | MNMD | Mind Medicine (Mindmed) Inc. | Sullivan Mark | GC | S - Sale | $6.74 | -6,576 | 316,621 | -2% | -$44,322 | ||||||
2025-03-25 | MNMD | Mind Medicine (Mindmed) Inc. | Liao Carrie | Chief Accounting Officer | S - Sale | $6.74 | -2,347 | 144,923 | -2% | -$15,819 | ||||||
2025-03-17 | BTMD | Biote Corp. | Heyer Andrew R | Dir | P - Purchase | $3.95 | +75,000 | 2,292,156 | +3% | +$296,043 | ||||||
2025-03-17 | BTMD | Biote Corp. | Christensen Bret | CEO | P - Purchase | $3.87 | +37,595 | 37,595 | New | +$145,493 | ||||||
2025-03-17 | BTMD | Biote Corp. | Cone Stephen Mark | Dir | P - Purchase | $3.88 | +38,104 | 160,829 | +31% | +$147,844 | ||||||
2025-03-17 | BTMD | Biote Corp. | Beer Marc D | Dir | P - Purchase | $3.87 | +107,794 | 107,794 | New | +$417,163 | ||||||
| M | 2025-03-13 | BTMD | Biote Corp. | Guines LLC | 10% | P - Purchase | $3.25 | +856,609 | 3,927,547 | +28% | +$2,784,419 | |||||
2025-03-12 | USNA | Usana Health Sciences Inc | Foukas Joshua | GC | S - Sale | $32.54 | -5,732 | 0 | -100% | -$186,514 | ||||||
2025-03-12 | USNA | Usana Health Sciences Inc | Neidig Brent | CHIEF COMMERCIAL OFFICER | S - Sale | $32.34 | -4,743 | 0 | -100% | -$153,387 | ||||||
2025-03-11 | USNA | Usana Health Sciences Inc | Fleming John Turman | Dir | S - Sale | $33.30 | -500 | 4,026 | -11% | -$16,648 | ||||||
2025-03-10 | USNA | Usana Health Sciences Inc | Mulham David Mulham | Chief Sales Officer | S - Sale | $32.98 | -3,234 | 12,775 | -20% | -$106,670 | ||||||
2025-03-06 | USNA | Usana Health Sciences Inc | Fuller Gilbert A | Dir | S - Sale | $31.44 | -674 | 0 | -100% | -$21,190 | ||||||
2025-03-07 | CDXC | Chromadex Corp. | Lopez Carlos Luis | SVP, GC | P - Purchase | $7.86 | +273 | 2,251 | +14% | +$2,146 | ||||||
2025-03-03 | USNA | Usana Health Sciences Inc | Brown Jim | CEO, Pres | S - Sale | $29.47 | -5,000 | 15,716 | -24% | -$147,350 | ||||||
2025-02-27 | USNA | Usana Health Sciences Inc | Pelosi Peggie | Dir | S - Sale | $28.10 | -780 | 3,395 | -19% | -$21,918 | ||||||
| M | 2025-01-23 | SNYR | Synergy Chc Corp. | Ross Jack | CEO, COB, 10% | P - Purchase | $3.92 | +15,200 | 4,732,127 | 0% | +$59,521 | |||||
| M | 2024-11-25 | SNYR | Synergy Chc Corp. | Ross Jack | CEO, COB, 10% | P - Purchase | $4.92 | +5,170 | 331,677 | +2% | +$25,460 | |||||
2025-01-15 | FTLF | Fitlife Brands, Inc. | Ordal Todd | Dir | P - Purchase | $30.37 | +150 | 31,094 | 0% | +$4,556 | ||||||
2024-12-31 | CGC | Canopy Growth Corp | Kruh Willy | Dir | S - Sale | $2.67 | -2,004 | 11,284 | -15% | -$5,351 | ||||||
2024-12-31 | CGC | Canopy Growth Corp | Yanofsky Theresa | Dir | S - Sale | $2.67 | -1,996 | 22,203 | -8% | -$5,329 | ||||||
2024-12-31 | CGC | Canopy Growth Corp | Mongeau Luc | Dir | S - Sale | $2.67 | -2,004 | 11,277 | -15% | -$5,351 | ||||||
2024-12-31 | CGC | Canopy Growth Corp | Lazzarato David Angelo | Dir | S - Sale | $2.67 | -3,006 | 25,890 | -10% | -$8,026 | ||||||
2024-12-26 | MNMD | Mind Medicine (Mindmed) Inc. | Barrow Robert | CEO | S - Sale | $7.43 | -19,106 | 526,666 | -4% | -$141,958 | ||||||
2024-12-26 | MNMD | Mind Medicine (Mindmed) Inc. | Liao Carrie | Chief Accounting Officer | S - Sale | $7.43 | -2,273 | 97,270 | -2% | -$16,888 | ||||||
2024-12-26 | MNMD | Mind Medicine (Mindmed) Inc. | Karlin Dan | Chief Medical Officer | S - Sale | $7.43 | -6,643 | 338,013 | -2% | -$49,357 | ||||||
2024-12-26 | MNMD | Mind Medicine (Mindmed) Inc. | Sullivan Mark | GC | S - Sale | $7.43 | -4,519 | 173,197 | -3% | -$33,576 | ||||||
| D | 2024-12-13 | CDXC | Chromadex Corp. | Jaksch Frank L Jr | Dir | S - Sale+OE | $6.19 | -37,161 | 2,319,231 | -2% | -$229,956 | |||||
2024-12-11 | TRUL | Trulieve Cannabis Corp. | Getman Wes | CFO | P - Purchase | $4.91 | +9,500 | 47,000 | +25% | +$46,645 | ||||||
2024-12-05 | MNMD | Mind Medicine (Mindmed) Inc. | Gryska David W | Dir | P - Purchase | $7.17 | +2,500 | 19,851 | +14% | +$17,925 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |